tiprankstipranks
Trending News
More News >
Inovio Pharmaceuticals (INO)
NASDAQ:INO
US Market
Advertisement

Inovio Pharmaceuticals (INO) Ratios

Compare
5,903 Followers

Inovio Pharmaceuticals Ratios

INO's free cash flow for Q2 2025 was $0.00. For the 2025 fiscal year, INO's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.66 3.60 3.25 6.82 11.30
Quick Ratio
1.66 3.60 3.25 6.82 11.30
Cash Ratio
0.77 0.34 0.48 1.08 6.01
Solvency Ratio
-1.72 -2.46 -2.24 -3.12 -2.68
Operating Cash Flow Ratio
-4.16 -2.92 -2.23 -3.28 -4.27
Short-Term Operating Cash Flow Coverage
-49.72 -7.42 0.00 0.00 0.00
Net Current Asset Value
$ 12.99B$ 99.51M$ 189.07M$ 352.17M$ 392.54M
Leverage Ratios
Debt-to-Assets Ratio
0.16 0.18 0.09 0.07 0.07
Debt-to-Equity Ratio
0.37 0.26 0.14 0.08 0.08
Debt-to-Capital Ratio
0.27 0.20 0.13 0.08 0.08
Long-Term Debt-to-Capital Ratio
0.22 0.00 0.07 0.04 0.04
Financial Leverage Ratio
2.39 1.46 1.57 1.24 1.17
Debt Service Coverage Ratio
-18.14 -7.25 -224.02 -154.26 -23.18
Interest Coverage Ratio
0.00 -117.71 -213.38 -155.55 -14.26
Debt to Market Cap
122.67 0.12 0.04 0.01 0.01
Interest Debt Per Share
274.48 1.42 1.68 2.01 3.69
Net Debt to EBITDA
0.28 -0.12 0.05 0.13 1.42
Profitability Margins
Gross Profit Margin
-745.52%-321.09%46.44%-166.56%-1171.66%
EBIT Margin
-35232.48%-16092.90%-2693.35%-16976.28%-2080.47%
EBITDA Margin
-26422532.71%-15671.81%-2639.80%-16709.72%-2018.02%
Operating Profit Margin
-12700267.40%-17300.28%-2607.35%-16972.34%-1674.25%
Pretax Profit Margin
-26721930.48%-16239.87%-2705.57%-17085.39%-2197.89%
Net Profit Margin
-37512391.17%-16239.87%-2803.13%-17207.13%-2902.17%
Continuous Operations Profit Margin
-35232.48%-16239.87%-2726.67%-17109.87%-2259.75%
Net Income Per EBT
140.38%100.00%103.61%100.71%132.04%
EBT Per EBIT
210.40%93.87%103.77%100.67%131.28%
Return on Assets (ROA)
-100.23%-79.04%-82.54%-61.58%-39.85%
Return on Equity (ROE)
-952.49%-115.14%-129.37%-76.41%-46.64%
Return on Capital Employed (ROCE)
-63.39%-112.12%-106.32%-70.02%-24.91%
Return on Invested Capital (ROIC)
-59.09%-97.55%-108.94%-70.09%-32.74%
Return on Tangible Assets
-100.23%-79.04%-85.64%-63.25%-40.88%
Earnings Yield
-108734.30%-99.57%-77.28%-29.31%-15.67%
Efficiency Ratios
Receivables Turnover
<0.01 0.35 0.87 0.22 0.39
Payables Turnover
0.00 0.75 0.26 0.17 64.18
Inventory Turnover
0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
<0.01 0.06 0.57 0.06 0.31
Asset Turnover
<0.01 <0.01 0.03 <0.01 0.01
Working Capital Turnover Ratio
<0.01 <0.01 0.03 <0.01 0.03
Cash Conversion Cycle
1.68M 570.90 -982.66 -506.33 933.20
Days of Sales Outstanding
1.68M 1.06K 417.50 1.65K 938.88
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
0.00 484.27 1.40K 2.16K 5.69
Operating Cycle
1.68M 1.06K 417.50 1.65K 938.88
Cash Flow Ratios
Operating Cash Flow Per Share
-3.40K -5.61 -10.87 -12.40 -13.77
Free Cash Flow Per Share
-3.40K -5.62 -10.92 -12.47 -13.89
CapEx Per Share
0.01 0.01 0.05 0.07 0.12
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.01 1.01
Dividend Paid and CapEx Coverage Ratio
-270.71K -387.55 -223.10 -175.23 -117.04
Capital Expenditure Coverage Ratio
-270.71K -387.55 -223.10 -175.23 -117.04
Operating Cash Flow Coverage Ratio
-12.39 -4.12 -6.74 -6.53 -4.56
Operating Cash Flow to Sales Ratio
-724.27K -149.48 -21.07 -121.54 -24.01
Free Cash Flow Yield
-153395.79%-91.88%-58.34%-20.82%-13.07%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
>-0.01 -1.00 -1.29 -3.41 -6.38
Price-to-Sales (P/S) Ratio
476.53 163.10 36.27 587.16 185.24
Price-to-Book (P/B) Ratio
<0.01 1.16 1.67 2.61 2.98
Price-to-Free Cash Flow (P/FCF) Ratio
>-0.01 -1.09 -1.71 -4.80 -7.65
Price-to-Operating Cash Flow Ratio
>-0.01 -1.09 -1.72 -4.83 -7.71
Price-to-Earnings Growth (PEG) Ratio
-0.01 0.02 0.07 -0.62 -0.47
Price-to-Fair Value
<0.01 1.16 1.67 2.61 2.98
Enterprise Value Multiple
0.28 -1.16 -1.32 -3.39 -7.76
Enterprise Value
-13.61B 151.60M 358.00M 1.00B 1.16B
EV to EBITDA
0.28 -1.16 -1.32 -3.39 -7.76
EV to Sales
-74.63K 182.21 34.88 565.68 156.68
EV to Free Cash Flow
0.10 -1.22 -1.65 -4.63 -6.47
EV to Operating Cash Flow
0.10 -1.22 -1.66 -4.65 -6.52
Tangible Book Value Per Share
734.76 5.29 10.55 22.21 34.62
Shareholders’ Equity Per Share
734.76 5.29 11.18 22.97 35.67
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 -0.04 >-0.01 -0.32
Revenue Per Share
<0.01 0.04 0.52 0.10 0.57
Net Income Per Share
-1.76K -6.09 -14.47 -17.55 -16.64
Tax Burden
1.40 1.00 1.04 1.01 1.32
Interest Burden
758.45 1.01 1.00 1.01 1.06
Research & Development to Revenue
168.06K 104.18 18.29 140.44 12.72
SG&A to Revenue
143.74K 57.19 8.79 30.29 5.03
Stock-Based Compensation to Revenue
33.52K 13.31 2.20 14.84 2.11
Income Quality
1.19 0.92 0.77 0.71 1.06
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis